olbas oil
ΓΡ. ΣΑΡΑΝΤΗΣ ΑΒΕΕ - ΈΛΑΙΟ ΕΥΚΑΛΎΠΤΟΥ, ΈΛΑΙΟ ΜΈΝΤΑΣ, cajuput oil, menthol, ΦΥΣΙΚΌ wintergreen ΓΕΎΣΗ ΚΈΔΡΟΥ, ΈΛΑΙΟ ΑΠΌ ΓΑΡΎΦΑΛΛΟ ΠΕΤΡΈΛΑΙΟ - ΔΙΑΛΥΜΑ - 0008000484 - eucalyptus oil - 354.500000 mg; 0008006904 - peppermint oil - 354.500000 mg; 0008008988 - cajuput oil - 185.000000 mg; 0000089781 - menthol - 41.500000 mg; ineof00619 - natural wintergreen flavour - 37.000000 mg; 0008012917 - juniper oil - 27.000000 mg; 0008000348 - clove oil - 1.000000 mg - other dermatologicals
tiger balm
olvos science ae - ΚΑΜΦΟΡΆ, ΜΈΝΤΑ, ΓΑΡΥΦΑΛΈΛΑΙΟ, cajuput oil - ΑΛΟΙΦΗ - 0000076222 - camphor - 110.000000 mg; 0000089781 - menthol - 100.000000 mg; 0008000348 - clove oil - 50.000000 mg; 0008008988 - cajuput oil - 70.000000 mg - various
tiger balm
olvos science ae - ΚΑΜΦΟΡΆ, ΜΈΝΤΑ, ΓΑΡΥΦΑΛΈΛΑΙΟ, cajuput oil - ΑΛΟΙΦΗ - (80+110+15+129)mg/g - 0000076222 - camphor - 110.000000 mg; 0000089781 - menthol - 80.000000 mg; 0008000348 - clove oil - 15.000000 mg; 0008008988 - cajuput oil - 129.000000 mg - various
caput spray
fatro s.p.a. (0000008561) via emilia 285, ozzano emilia (bologna), 40064 - piperonyl butoxide; pyrethrum extract - spray - piperonyl butoxide (0000051036) 4.32g; pyrethrum extract (0008003347) 2.16g - pyrethrum combinations
caput spray, pyrethrines and piperonyl butoxide, antiparasitic spray for topical use for dogs and cats
qp53ac51 - granted - fatro spa italy - n. a. chance trading co
benlysta
glaxosmithkline (ireland) limited - belimumab - lupus erythematosus, συστημικό - Ανοσοκατασταλτικά - benlysta ενδείκνυται ως συμπληρωματική θεραπεία σε ασθενείς ηλικίας 5 ετών και άνω με την ενεργό, αυτοαντίσωμα θετικό συστηματικός ερυθηματώδης λύκος (ΣΕΛ) με υψηλό βαθμό δραστηριότητας της νόσου (ε. , θετικό αντι dsdna και χαμηλό συμπλήρωμα), παρά την τυπική θεραπεία. benlysta is indicated in combination with background immunosuppressive therapies for the treatment of adult patients with active lupus nephritis.
saphnelo
astrazeneca ab - anifrolumab - lupus erythematosus, συστημικό - Ανοσοκατασταλτικά - saphnelo is indicated as an add-on therapy for the treatment of adult patients with moderate to severe, active autoantibody-positive systemic lupus erythematosus (sle), despite standard therapy.
lupkynis
otsuka pharmaceutical netherlands b.v. - voclosporin - lupus nephritis - Ανοσοκατασταλτικά - lupkynis is indicated in combination with mycophenolate mofetil for the treatment of adult patients with active class iii, iv or v (including mixed class iii/v and iv/v) lupus nephritis (ln).
minaxen 50mg capsule,hard
delorbis pharmaceuticals ltd (0000009620) 17 athinon street, ergates industrial area, lefkosia, 2081, 28629 - minocycline hydrochloride - capsule,hard - 50mg - minocycline hydrochloride (0013614987) 53,98mg - minocycline
seizal 200mg tablet, dispersible
delorbis pharmaceuticals ltd (0000009620) 17 athinon street, ergates industrial area, lefkosia, 2081, 28629 - lamotrigine - tablet, dispersible - 200mg - lamotrigine (0084057841) 200mg - lamotrigine